867 — China Medical System Holdings Share News
0.000.00%
Last trade - 00:00- HK$24.82bn
- HK$19.26bn
- CNY8.21bn
Brief: China Medical System Says New Drug Application Of Tildrakizumab Injection Approved In China
Brief: China Medical System Announces Establishment Of JV By Rxilient And Junshi Biosciences
Brief: China Medical System Holdings Says New Drug Application Of Methotrexate Injection Approved
Brief: China Medical System Proposes Final Dividend Of RMB0.2414 Per Share
Brief: China Medical System Says NDA For Oral Diagnostic Drug Accepted By NMPA
Incyte Corp rises on collaboration deal for skin disease cream
Brief: Incyte And CMS Announce Collaboration And License Agreement For Ruxolitinib Cream In Greater China And Southeast Asia
Brief: China Medical System Says Entered Into License, Collaboration And Distribution Deal
Brief: CMS Releases Its 2022 Interim Report
Brief: China Medical System Holdings Says HY Profit Up 10.1% To RMB1,796.3 Mln
Brief: China Medical System Says Group Via Unit Made Equity Investment In Heling Medical (Guangzhou)
Brief: China Medical System Holdings - Via Unit Entered License, Collaboration And Supply Agreement With Hefei Tianmai Biotechnology Development
Brief: China Medical System Says Entered License, Collaboration & Distribution Agreement
Brief: China Medical System Says Co, Via Unit, Entered An Asset Transfer With Wuhan Yzy Biopharma
Brief: China Medical System Says Profit For Year Is Up 18.4%
Brief: China Medical System Says, Via Unit Signed An Exclusive Collaboration Agreement With Ovmedi Co
Brief: China Medical System Says NDA Of Methotrexate Injection Accepted By NMPA
HK-listed China Medical jumps most in nearly 9 months on expansion deal
Brief: China Medical System Through Unit Acquires Shanghai Xuli Medical Devices Co